1	Lipopolysaccharide	Lipopolysaccharide	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	tumor	tumor	_	_	_	_	_	_	_
6	necrosis	necrosis	_	_	_	_	_	_	_
7	factor-alpha	factor-alpha	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	monocytic	monocytic	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Regulation	Regulation	_	_	_	_	_	_	_
2	by	by	_	_	_	_	_	_	_
3	Egr-1	Egr-1	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	c-Jun	c-jun	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Biosynthesis	biosynthesis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	tumor	tumor	_	_	_	_	_	_	_
4	necrosis	necrosis	_	_	_	_	_	_	_
5	factor-alpha	factor-alpha	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	predominantly	predominantly	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	monocytic	monocytic	_	_	_	_	_	_	_
16	lineage	lineage	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	role	role	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	various	various	_	_	_	_	_	_	_
8	cis-acting	cis-acting	_	_	_	_	_	_	_
9	regulatory	regulatory	_	_	_	_	_	_	_
10	elements	element	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	LPS	LPS	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	induction	induction	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	monocytic	monocytic	_	_	_	_	_	_	_
27	lineage	lineage	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Functional	functional	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	monocytic	monocytic	_	_	_	_	_	_	_
5	THP-1	thp-1	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	transfected	transfecte	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	plasmids	plasmid	_	_	_	_	_	_	_
10	containing	contain	_	_	_	_	_	_	_
11	various	various	_	_	_	_	_	_	_
12	lengths	length	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
15	promoter	promoter	_	_	_	_	_	_	_
16	localized	localize	_	_	_	_	_	_	_
17	enhancer	enhancer	_	_	_	_	_	_	_
18	elements	element	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	region	region	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	-182	-182	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	-37	-37	_	_	_	_	_	_	_
26	base	base	_	_	_	_	_	_	_
27	pairs	pair	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	bp	bp	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	that	that	_	_	_	_	_	_	_
33	were	be	_	_	_	_	_	_	_
34	required	require	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	optimal	optimal	_	_	_	_	_	_	_
37	transcription	transcription	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
41	gene	gene	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	response	response	_	_	_	_	_	_	_
44	to	to	_	_	_	_	_	_	_
45	LPS	LPS	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

1	Two	two	_	_	_	_	_	_	_
2	regions	region	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	identified	identify	_	_	_	_	_	_	_
5	:	:	_	_	_	_	_	_	_
6	region	region	_	_	_	_	_	_	_
7	I	i	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	-182	-182	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	-162	-162	_	_	_	_	_	_	_
12	bp	bp	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	contained	contain	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	overlapping	overlap	_	_	_	_	_	_	_
17	Sp1/Egr-1	sp1/egr-1	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	region	region	_	_	_	_	_	_	_
22	II	ii	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	-119	-119	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	-88	-88	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	contained	contain	_	_	_	_	_	_	_
29	CRE	CRE	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	designated	designate	_	_	_	_	_	_	_
34	kappaB3	kappab3	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	sites	site	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	unstimulated	unstimulated	_	_	_	_	_	_	_
3	THP-1	thp-1	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	CRE-binding	cre-binding	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	lesser	less	_	_	_	_	_	_	_
12	extent	extent	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	c-Jun	c-jun	_	_	_	_	_	_	_
15	complexes	complex	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	found	find	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	bind	bind	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	CRE	CRE	_	_	_	_	_	_	_
23	site	site	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	LPS	LPS	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	increased	increase	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	c-Jun-containing	c-jun-containing	_	_	_	_	_	_	_
8	complexes	complex	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	LPS	LPS	_	_	_	_	_	_	_
5	stimulation	stimulation	_	_	_	_	_	_	_
6	induced	induce	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	cognate	cognate	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factors	factor	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	Egr-1	egr-1	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	kappaB3	kappab3	_	_	_	_	_	_	_
18	sites	site	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	which	which	_	_	_	_	_	_	_
21	were	be	_	_	_	_	_	_	_
22	identified	identify	_	_	_	_	_	_	_
23	as	as	_	_	_	_	_	_	_
24	Egr-1	egr-1	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	p50/p65	p50/p65	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	respectively	respectively	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	CRE	CRE	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	kappaB3	kappab3	_	_	_	_	_	_	_
5	sites	site	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	region	region	_	_	_	_	_	_	_
8	II	ii	_	_	_	_	_	_	_
9	together	together	_	_	_	_	_	_	_
10	conferred	confer	_	_	_	_	_	_	_
11	strong	strong	_	_	_	_	_	_	_
12	LPS	lps	_	_	_	_	_	_	_
13	responsiveness	responsiveness	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	heterologous	heterologous	_	_	_	_	_	_	_
17	promoter	promoter	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	whereas	whereas	_	_	_	_	_	_	_
20	individually	individually	_	_	_	_	_	_	_
21	they	they	_	_	_	_	_	_	_
22	failed	fail	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	provide	provide	_	_	_	_	_	_	_
25	transcriptional	transcriptional	_	_	_	_	_	_	_
26	activation	activation	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	increasing	increase	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	spacing	spacing	_	_	_	_	_	_	_
6	between	between	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	CRE	CRE	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	kappaB3	kappab3	_	_	_	_	_	_	_
12	sites	site	_	_	_	_	_	_	_
13	completely	completely	_	_	_	_	_	_	_
14	abolished	abolish	_	_	_	_	_	_	_
15	LPS	LPS	_	_	_	_	_	_	_
16	induction	induction	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	suggesting	suggest	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	cooperative	cooperative	_	_	_	_	_	_	_
21	interaction	interaction	_	_	_	_	_	_	_
22	between	between	_	_	_	_	_	_	_
23	c-Jun	c-jun	_	_	_	_	_	_	_
24	complexes	complex	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	p50/p65	p50/p65	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	maximal	maximal	_	_	_	_	_	_	_
6	LPS	lps	_	_	_	_	_	_	_
7	induction	induction	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	mediated	mediate	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	concerted	concerted	_	_	_	_	_	_	_
16	participation	participation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	at	at	_	_	_	_	_	_	_
19	least	least	_	_	_	_	_	_	_
20	two	two	_	_	_	_	_	_	_
21	separate	separate	_	_	_	_	_	_	_
22	cis-acting	cis-acting	_	_	_	_	_	_	_
23	regulatory	regulatory	_	_	_	_	_	_	_
24	elements	element	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

